🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 29% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

10 Gram(s) Serving Size
30 Servings
Other Combinations Product Type
29% Evidence Coverage

Supplement Facts — Evidence Check

Calories
15 Calorie(s)
Total Carbohydrates
4 Gram(s) (1% DV)
Protein
3 Gram(s)
Potassium
300 mg (6% DV)
📊 Market median: 500.0mg (180 products) 📚 5 studies (Tier A: 0, B: 1)
This product: 3000mg
📊 Market median: 100.0mg (284 products) 📚 10 studies (Tier A: 0, B: 4)
This product: 100mg
100 mcg
📊 Market median: 0.15mg (41 products)
Median 0.15mg This product: 0.1mg

Other Ingredients

Fructose Citric Acid Malic Acid Orange Juice, Powder Orange Flavor Silicon Dioxide Rebaudioside A Luo Han Guo fruit extract Stearic Acid

Label Claims — Verification

All Other
Structure/Function
All Other (98% of products) Structure/Function (78% of products) Nutrient (56% of products)

Target Groups

Adult (18 - 50 Years) Women (not pregnant or lactating) Gluten Free Dairy Free

Product Information

📋 Directions for Use

Directions for use: Pour 3 level, white bottle capfuls of powder into a cup. Add 6 fl oz/180 mL (line on the overcap indicates 2 fl oz/60 mL) of water and stir. As a dietary supplement, take once daily or as directed by your healthcare provider. Do not exceed 2 servings (6 capfuls) per day. Maximum absorption occurs when taken on an empty stomach. This product is isotonic only if the specified amounts of powder and water are used.

⚠️ Warnings & Precautions

Do not exceed 2 servings (6 capfuls) per day.

Warning: If you are currently using anticholinergic drugs, warfarin (Coumadin), other antiplatelet/anticoagulant drugs, or levodopa, consult your healthcare provider before using this product. If you are currently using any other prescription drugs or have an ongoing medical condition, consult your healthcare provider before using this product. If you are pregnant or breastfeeding, do not use this product. This supplement contains Huperzine A. Huperzine A is a reversible inhibitor of acetylcholinesterase and may cause cholinergic side effect. Caution should be used if you are taking drugs that promote or suppress acetylcholine activity.

Keep out of the reach of children.

Do not use if safety seal is broken or missing.

Resale on third-party websites is strictly prohibited unless specifically authorized by Market America or its corporate affiliates. If barcodes are altered or you purchase this product from an unauthorized third-party website, the product is not guaranteed by Market America or its corporate affiliates.

Contains: Soy.

🧪 Formulation Notes

Promotes healthy muscle retention and use Aids in improving and enhancing memory Helps reduce muscle fatigue

Anti-aging nutraceuticals

This product contains no added wheat, yeast, gluten, artificial flavor, starch, salt, preservatives or milk.

Manufactured in an FDA Registered Facility using Good Manufacturing Practices (GMPs).

Additional Information

Store in a cool, dry place.

Product Details

UPC / SKU 8 48570 00632 5
DSLD Entry Date 2024-07-25
Product Type Other Combinations
Form Powder
DSLD ID 313433
Data Updated 2026-04-11

Research Evidence

50 Research Sources
47 Avg Quality Score
28 Rct
13 Clinical Trial
5 Guideline
4 Systematic Review
A Using a Novel Consensus-Based Chemoinformatics Approach to Predict ADMET Properties and Druglikeness of Tyrosine Kinase Inhibitors.
Guideline International journal of molecular sciences 2025
B Australia and New Zealand consensus statement on the cardiovascular management of patients with chronic lymphocytic leukaemia treated with Bruton's tyrosine kinase inhibitors.
Guideline Internal medicine journal 2025
B Branched-chain amino acid supplementation for improving growth and development in term and preterm neonates
Systematic Review The Cochrane database of systematic reviews 2020
B [Clinical practice guideline on anaplastic lymphoma kinase-tyrosine kinase inhibitors for non-small cell lung cancer (2025 edition)].
Guideline Zhonghua zhong liu za zhi [Chinese journal of oncology] 2025
B [Chinese expert consensus on epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer (2025 edition)].
Guideline Zhonghua yi xue za zhi 2025
B Consensus Guideline for the Diagnosis and Treatment of Tyrosine Hydroxylase (TH) Deficiency.
Guideline Journal of inherited metabolic disease 2025
B Baseline-dependent effect of dopamine's precursor L-tyrosine on working memory gating but not updating
Rct Cognitive, affective & behavioral neuroscience 2020
B Effect of Amino Acid Supplementation on Iron Regulation after Endurance Exercise
Rct Nutrients 2023
C Attenuating Muscle Damage Biomarkers and Muscle Soreness After an Exercise-Induced Muscle Damage with Branched-Chain Amino Acid (BCAA) Supplementation: A Systematic Review and Meta-analysis with Meta-regression
Systematic Review Sports medicine - open 2024
C The Effects of Green Tea Amino Acid L-Theanine Consumption on the Ability to Manage Stress and Anxiety Levels: a Systematic Review
Systematic Review Plant foods for human nutrition (Dordrecht, Netherlands) 2020
View all evidence for Tyrosine →

Compare Similar Products

View all Tyrosine products →